Company / SG&A per Share
Edwards Lifesciences SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.59
FY2025
5-year range
$2.23 / $3.59
FY2021-FY2025
Trend
+20.6%
vs FY2024
Sector context
#98 of 156
Health Care
What the data says
At $3.59, Edwards Lifesciences's sg&a per share ranks #59 of 156 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $2.23 in FY2022 to $3.59 in FY2025.
Based on SEC 10-K filings.
3.59 in FY2025 with a 5-year CAGR of +12.8%.
Increased from $2.46 to $3.59 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
#59 of 156 in Health CareTop 37% of 156This company $3.59 Sector average $11421.56
▼
-100.0% below sector average
Key checks
Key Insights
- Edwards Lifesciences's sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 20.6% year-over-year.
- Ranks #98 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.59 | +20.6% |
| FY2024 | $2.98 | +21.2% |
| FY2023 | $2.46 | +10.0% |
| FY2022 | $2.23 | -6.8% |
| FY2021 | $2.39 | +21.6% |
| FY2020 | $1.97 | -66.9% |
| FY2019 | $5.94 | +13.4% |
| FY2018 | $5.24 | +11.9% |
| FY2017 | $4.68 | +9.5% |
| FY2016 | $4.28 | -45.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026